Skip to main content

Liu Joy's Form 4 filing

Vertex Pharmaceuticals Inc (VRTX) · filed Aug 17, 2022

Accession no.
0000899243-22-029023
Filed
Aug 17, 2022
Trade date
Aug 15, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions. Open-market sales total $1.14M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Liu JoyCIK 0001847529Officer (SVP, General Counsel)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 15, 2022Common StockSSaleDisposed−206$300.26F2,F3−$61,853.5613,146Direct
Aug 15, 2022Common StockSSaleDisposed−698$301.63F2,F4−$210,537.7412,448Direct
Aug 15, 2022Common StockSSaleDisposed−100$302.35−$30,23512,348Direct
Aug 15, 2022Common StockSSaleDisposed−700$303.99F2,F5−$212,79311,648Direct
Aug 15, 2022Common StockSSaleDisposed−1,743$305.01F2,F6−$531,632.439,905Direct
Aug 15, 2022Common StockSSaleDisposed−300$305.57F2,F7−$91,6719,605Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.

Referenced by the price of 5 transactions in Table I.

F3

Open market sales reported on this line occurred at a weighted average price of $300.26 (range $300.00 to $300.28).

Referenced by the price of 1 transaction in Table I.

F4

Open market sales reported on this line occurred at a weighted average price of $301.63 (range $301.23 to $302.01).

Referenced by the price of 1 transaction in Table I.

F5

Open market sales reported on this line occurred at a weighted average price of $303.99 (range $303.48 to $304.46).

Referenced by the price of 1 transaction in Table I.

F6

Open market sales reported on this line occurred at a weighted average price of $305.01 (range $304.54 to $305.53).

Referenced by the price of 1 transaction in Table I.

F7

Open market sales reported on this line occurred at a weighted average price of $305.57 (range $305.55 to $305.58).

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)